Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });

2022-11-26 HKT 09:22

Share this story

facebook

  • Omicron boosters available from next month

Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.

The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.

"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."

Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.

The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.

The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.

mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.

RECENT NEWS

Revolut Considers China Expansion Amid UK Regulatory Hurdles

UK fintech giant Revolut is exploring a potential move into China, setting the stage for competition with domestic heav... Read more

ZA Global Backs RD Technologies With US$40M To Boost HKs Stablecoin Ecosystem

ZA Global has led a US$40 million Series A2 funding round for HK fintech firm, RD Technologies (RD), marking a signific... Read more

WeLab Hit Profitability And Now Wants 500 Million Customers Across Asia

From its humble beginnings as an online lender to its rise as one of Asia’s most ambitious fintechs, WeLab Group (WeL... Read more

HKMA Finalises Guidelines For Stablecoin Issuer Regulatory Regime

The Hong Kong Monetary Authority (HKMA) has published several documents in preparation for the implementation of the re... Read more

Cybercrime Is Surging Across APAC Yet Defences Remain Fragmented

APAC saw a sharp rise in human-led attacks in 2024, with attack rates growing over 60% year-on-year and increasing 37% ... Read more

Hong Kong Advances Trade Digitalisation With MLETR Adoption

Digitalisation is reshaping the global economy, and businesses must adapt to capitalise on emerging opportunities. In t... Read more